| Patents for C07C 275 - Derivatives of urea, i.e. compounds containing any of the groups the nitrogen atoms not being part of nitro or nitroso groups (9,848) |
|---|
| 06/05/2002 | CN1085980C Meta-guanidine, urea, thiourea or azacyclic amino benzoic and derivatives as integrin antagaonists |
| 06/04/2002 | US6399809 From malonic acid monoester amide |
| 06/04/2002 | US6399798 Method of preparing alkylated salicylamides |
| 05/30/2002 | WO2002042257A1 Substituted cyclohexane derivates and the use thereof in medicaments for treating cardiovascular diseases |
| 05/30/2002 | WO2002042248A2 Naphthalene derivatives |
| 05/30/2002 | WO2002014264A3 (hydroxyethyl)ureas as inhibitors of alzheimer's beta-amyloid production |
| 05/30/2002 | WO2001021160B1 Carboxymide and aniline derivatives as selective inhibitors of pathogens |
| 05/30/2002 | US20020065316 Citrullimycines, a process for their production and their use as pharmaceuticals |
| 05/30/2002 | CA2429328A1 Substituted cyclohexane derivates and the use thereof in medicaments for treating cardiovascular diseases |
| 05/29/2002 | EP1209147A1 Carboxylic acid derivatives and adhesion molecule inhibitors containing the same as the active ingredient |
| 05/29/2002 | EP1208091A1 Benzophenones as inhibitors of reverse transcriptase |
| 05/23/2002 | WO2002040446A1 Glucagon antagonist/inverse agonist |
| 05/23/2002 | WO2002040445A1 Glucagon antagonists/inverse agonists |
| 05/23/2002 | WO2002040444A1 Glucagon antagonists/inverse agonists |
| 05/23/2002 | WO2002039967A1 Novel coupler for use in oxidative hair dyeing |
| 05/23/2002 | WO2001098235A3 3,4-dihydroxybenzyl-substituted carbonic acid derivatives and the use thereof as antioxidants |
| 05/23/2002 | US20020061916 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 05/23/2002 | CA2424723A1 Novel coupler for use in oxidative hair dyeing |
| 05/22/2002 | EP0966434B1 Aminophenol derivatives and their use in cosmetics |
| 05/22/2002 | EP0681575B1 Process for the preparation of Baccatin III analogs bearing new C2 and C4 functional groups |
| 05/22/2002 | CN1350565A Nucleators for crystallizable thermoplastic polymers |
| 05/22/2002 | CN1350452A Preventive or therapeutic drugs for diabetes |
| 05/21/2002 | US6392001 Process for the production of light-stable polyisocyanates containing allophanate groups |
| 05/21/2002 | US6391917 Analgesic |
| 05/21/2002 | CA2230750C Antiherpes peptidomimetic compounds |
| 05/16/2002 | WO2002038534A2 Substituted alkyldiamines as inhibitors of plasmepsin or related proteases |
| 05/16/2002 | US20020058784 Generation of preferential compound; obtain sample of diamino acid such as 2,3 diaminopropionic acid, incubate with compound with free amino group, recover urein |
| 05/16/2002 | US20020058654 For therapy of uterine fibroids, endometriosis, polycystic ovarian disease, dysfunctional uterine bleeding, breast cancer and ovarian cancer; depletion of oocytes; spermatocyte depletion; for female and male contraception |
| 05/16/2002 | CA2428266A1 Substituted alkyldiamines as inhibitors of plasmepsin or related proteases |
| 05/15/2002 | EP1204408A2 An improved form of form i celiprolol hydrochloride |
| 05/15/2002 | CN1349521A Compounds and methods for treatment of asthma, allergy and inflammatory disorders |
| 05/15/2002 | CN1349519A Glucokinase activators |
| 05/14/2002 | US6388153 Chain transfer agents |
| 05/14/2002 | US6388094 Method for making intermediates useful in synthesis of retroviral protease inhibitors |
| 05/14/2002 | US6387949 Substituted urea compounds useful in pain management |
| 05/10/2002 | WO2002036553A2 Substituted alkanoic acids |
| 05/08/2002 | EP1203765A2 Process for the synthesis of urea |
| 05/08/2002 | CN1348443A N-substituted-N'-substituted urea derivative and medicinal compositions containing the same |
| 05/07/2002 | US6384220 Antidiabetic agents increasing the expression of glucokinase (gk) to improve glucose tolerance; increase in glucose exposure coupled through gk in beta-cells to increase insulin secretion and in hepatocytes to increase glycogen deposition |
| 05/07/2002 | US6384174 Polyurethanes |
| 05/07/2002 | US6384075 Treating diseases in which mast cell dysfunction is involved |
| 05/02/2002 | WO2001081298A3 Cyclic carboxylic acids as integrin antagonists |
| 05/02/2002 | US20020052417 Factor VIIa inhibitory (thio)urea derivatives, their preparation and their use |
| 05/02/2002 | US20020052370 Including the treatment of female sexual dysfunction especially female sexual arousal disorder |
| 05/02/2002 | US20020052348 Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase |
| 05/02/2002 | US20020052028 Bio-intermediates for use in the chemical synthesis of polyketides |
| 05/02/2002 | EP1201648A1 Carbamate derivatives and agricultural/horticultural bactericides |
| 05/02/2002 | EP1200395A1 Urea derivatives as inhibitors of ccr-3 receptor |
| 05/01/2002 | CN1347404A (-)-Verbenzone derivs. |
| 05/01/2002 | CN1347318A Inhibitors of IMPDH enzyme |
| 05/01/2002 | CN1083831C Novel tricyclic compounds and drug compositions contg. same |
| 04/30/2002 | US6380392 Complexes |
| 04/25/2002 | US20020049236 Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
| 04/24/2002 | EP1198456A2 Potassium channel openers |
| 04/23/2002 | US6376546 Biphenyl-5-alkanoic acid derivatives and use thereof |
| 04/23/2002 | US6376538 Antiinflammatory agents; autoimmune diseases |
| 04/18/2002 | WO2002030915A2 Aryl-indane compounds for use as inhibitors of p-glycoprotein mediated transport |
| 04/18/2002 | WO2002030876A2 Cyclic carboxylic acids as integrin antagonists |
| 04/18/2002 | WO2002030875A1 Beta-amino acid derivatives as integrin receptor antagonists |
| 04/18/2002 | WO2002030874A2 Aliphatic, cyclic amino carboxylic acids as integrin antagonists |
| 04/18/2002 | WO2002003995A3 Treatment of male sexual dysfunction |
| 04/18/2002 | US20020045777 Used to treat hypercholesterolemia, hyperlipemia, arteriosclerosis, vascular diseases, mycoses, gallstones, hyperproliferative disorders, and treatment and/or prophylaxis of impaired glucose tolerance and diabetes. |
| 04/18/2002 | US20020045749 Antibacterial agents |
| 04/18/2002 | CA2424951A1 Beta-amino acid derivatives as integrin receptor antagonists |
| 04/17/2002 | CN1344711A Combined prep. of ammonia and urea |
| 04/16/2002 | US6372933 Reacting benzoxazolinone with nucleophilic aniline derivative in presence of lewis acid to open oxazolinone ring to form phenyl urea compound |
| 04/11/2002 | WO2002028824A1 Citrullimycines, a process for their production and their use as pharmaceuticals |
| 04/11/2002 | WO2002028820A1 Nitroso diphenylamine derivatives |
| 04/11/2002 | WO2001045678A3 Medicament, a method for its production and the use thereof |
| 04/11/2002 | US20020042517 Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| 04/11/2002 | US20020042512 Alpha-acyl- and alpha-heteroatom-substituted benzene acetamide glucokinase activators |
| 04/11/2002 | CA2424684A1 Nitroso diphenylamine derivatives |
| 04/11/2002 | CA2424273A1 Citrullimycines, a process for their production and their use as pharmaceuticals |
| 04/10/2002 | CN1344259A Processes and intermediates for prepn. of 1,3-diazin-b 6-ones and uracils |
| 04/10/2002 | CN1344247A Multicyclic compounds which inhibit beukocyte adhesion mediated by VLA-4 |
| 04/09/2002 | US6369073 Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase |
| 04/04/2002 | WO2002026701A2 Ionic liquids and their use as solvents |
| 04/04/2002 | WO2002004407A3 7-substituted tetracycline compounds |
| 04/04/2002 | WO2001094301A3 Factor viia inhibitory (thio)urea derivatives, their preparation and their use |
| 04/04/2002 | DE10044792A1 Substituierte Phenylcyclohexancarbonsäureamide und ihre Verwendung Substituted Phenylcyclohexancarbonsäureamide and their use |
| 04/03/2002 | EP1193249A1 Citrullimycines, a process for their production and their use as pharmaceuticals |
| 04/03/2002 | EP1047719B1 Mixtures containing diisocyanates with allophanate groups derived from alicyclic alcohols |
| 03/28/2002 | WO2002024635A2 Aminoalcohol derivatives |
| 03/28/2002 | WO2002024613A2 Resorcinol derivatives |
| 03/28/2002 | US20020038025 For therapy and prophylaxis of hypercholesterolemia, hyperlipemia, arteriosclerosis, vascular diseases, mycoses, parasite infections, gallstones, tumors and/or hyperproliferative disorders, diabetes |
| 03/28/2002 | US20020037905 N-phenyl-N'-(2-carboxyphenyl) urea, for example; chloride channel blockers; such as for treating bone metabolic disorders |
| 03/28/2002 | US20020037854 Use of at least one no synthase inhibitor for treating sensitive skin |
| 03/28/2002 | CA2423262A1 Resorcinol derivatives |
| 03/27/2002 | EP1190710A1 Preventive or therapeutic drugs for diabetes |
| 03/27/2002 | EP1189612A1 Vla-4 inhibitor compounds |
| 03/27/2002 | EP0832079B1 Anti-ischaemic hydroxylamine derivatives and pharmaceutical compositions |
| 03/26/2002 | US6362360 Sensitizers for insulin resistance and associated conditions dyslipidemia and hyperglycemia |
| 03/26/2002 | US6362210 Carboxylic acid amides, pharmaceutical compositions containing these compounds and their use |
| 03/21/2002 | WO2002022844A1 Optically active fluorophenylalanine derivative and process for producing the same |
| 03/21/2002 | WO2002022627A2 Ligands for metabotropic glutamate receptors |
| 03/21/2002 | WO2002022592A2 Substituted urea neuropeptide y y5 receptor antagonists |
| 03/21/2002 | WO2001055081A3 Esters of fatty acids and juvenoid alcohols, and a method of their preparation and use |
| 03/21/2002 | US20020035293 Process for the integrated preparation of ammonia and urea |
| 03/21/2002 | US20020035137 Amino (oxo) acetic acid protein tyrosine phosphatase inhibitors |
| 03/21/2002 | US20020035114 Substituted dimeric compounds |